INTRODUCTION
A physiological role for the calpains has not yet been clearly identified in any cell [1, 2] , but there is some evidence that hydrolysis by calpain of platelet substrates may contribute to platelet aggregation [3] . It is known that: (a) calpain I is a major neutral protease of platelets [4, 5] ; (b) calpain is acitvated in vitro by Ca2", phospholipids and membranes [1] ; (c) many agonists increase [Ca2+]1 in platelets [6, 7] ; (d) hydrolysis of various assumed calpain substrates (ABP, PKC and others) accompanies platelet aggregation [8] [9] [10] [11] .
Although it therefore seems likely that calpain is involved in platelet aggregation, some uncertainties remain. The fact that the calpain inhibitor leupeptin inhibits thrombin-induced aggregation of platelets had been taken as evidence for a role of calpain in aggregation [12, 13] , but it has now been shown that leupeptin inhibits thrombin directly [14] [15] [16] . In addition, an enormous range of calpain substrates has been proposed, and it is not obvious that hydrolysis of all ofthese can be necessary for the very rapid events of the platelet response.
The action of calpain is frequently inferred from the appearance of breakdown products of its supposed substrates, although this very strictly does not prove that calpain is responsible. However, the presence of proteolytically active calpain I can be observed directly by immunoblot detection of the 76 kDa-and 78 kDa-subunit active forms [17] . We were incubated with 1 ,tM-fura-2AM at 37°C for 30 min, followed by centrifugation and resuspension in buffer B at a concentration of 108 platelets/ml [18] . The platelets were stirred at 37°C in the fluorimeter, and [Ca2+]i was calculated from the fura-2 fluorescence as described [19] .
(ii) The [Ca2"],., was: (a) 2 mM-Ca2`when Ca21 was added just before activation; (b) low, probably less than 20/M [20] , when Ca21 was not specifically added, since the platelets had been washed several times in citrate buffer; (c) less than 0.1 /M if EDTA was added.
Determination of the calpain I 80 kDa to 76 + 78 kDa conversion Platelet incubations were terminated by addition of excess EDTA, portions of the platelet suspensions were mixed immediately with 1 vol. of SDS-gel sample buffer preheated to 95°C, and the mixtures were then heated at 95°C for 5 min. Gel electrophoresis and immunoblotting were performed as described [ [26] .
As in the thrombin work, leupeptin did not affect calpain activation in the presence of A23187, in agreement with a recent report [27] , or with PMA, showing that leupeptin did not enter the platelets in our reaction conditions in amounts sufficient to inhibit calpain.
ABP hydrolysis was not detectable by immunoblotting in these 10 min incubations even when calpain was about 20-30 % activated. However, in agreement with previous work [3, 8, 9] , ABP hydrolysis was observed, together with much greater calpain activation, in platelets stirred for 20-30 min with 2 mM-Ca2+ext and A23187 or thrombin (result not shown). No change in the 30 kDa subunit of calpain [28] was observed by immunoblotting when the 80 kDa subunit was extensively activated, although it has been suggested that proteolysis of the 30 kDa subunit is of regulatory significance [1] .
Indomethacin (20 /SM), which is used to inhibit thomboxane synthesis, had no detectable effect on aggregation or calpain activation in the experiments described.
Calpain I activation therefore was not correlated with aggregation, nor was it correlated, surprisingly, with the rise in [Ca2+]i as detected by fura-2. It was correlated only with stirring of platelets in the presence of both 2 mMCa2+ext and an agonist. Aside from various conceivable indirect mechanisms, one possibility is that 2 mM-Ca2 ext and an agonist create a high local plasma-membrane [Ca2+] which is not detected by cytoplasmic fura-2, but can assist in activation of membrane-bound calpain. Calpain activation in vivo is normally assumed to involve membrane binding [1] , although we have shown (in Ca2+-loaded erythrocytes) that calpain I did not become membrane-bound, except perhaps transiently [29] , so that this point remains to be clarified.
If calpain does not have an obligatory role in platelet activation, it remains possible that calpain facilitates some steps in the platelet response, or has other as yet unidentified functions. In this context, two roles have been proposed for calpain in post-aggregation events. Both assume that hydrolysis of the cytoskeleton leads, via alterations in the platelet membrane, either to effects 1989 on clot retraction [22] or to promotion of the surface prothrombinase activity [30] . It is assumed that the pro-enzyme 80 kDa form of calpain I has no intrinsic activity, although that is difficult to prove. Also, the methods used cannot detect very low levels either of calpain activation or of hydrolysis of the proposed substrates. Given those reservations, the experimental results outlined in Table I demonstrate that detectable calpain activation is not essential to platelet aggregation and secretion, and they suggest that extensive hydrolysis of cytoskeletal protein is also not essential for these events; conversely, they demonstrate that extensive calpain activation can occur without aggregation.
The most important question which remains may be whether a very low percentage of these reactions is physiologically relevant in the very rapid events of platelet aggregation in vivo.
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